2016-11-14T09:38:03-06:00 2015-12-31 521511275 RAFFA PC 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2015-01-01 510178702 RADIATION ONCOLOGY INSTITUTE RADI 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 7035021550 2016-11-14 1 FRANK H SMITH P00639053 2028225000 2016-11-14 2015 2017-02-10 21:41:12Z X LAURA I THEVENOT 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 4863155 0 X WWW.ROINSTITUTE.ORG X 1978 IL TO ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER. 10 10 0 61 0 0 1313127 588656 0 0 758421 592194 0 0 2071548 1180850 10000 126045 0 0 146208 105320 100254 99888 164146 466855 467909 723317 799162 1348231 381688 11994078 11561342 122816 17124 11871262 11544218 X THE RADIATION ONCOLOGY INSTITUTE (ROI) WILL ENHANCE AND PROMOTE THE CRITICAL ROLE OF RADIATION THERAPY IN THE TREATMENT OF CANCER BY SUPPORTING RESEARCH AND EDUCATION ABOUT THE LIVE-SAVING AND QUALITY-OF-LIFE BENEFITS OF RADIATION THERAPY. 0 1 127908 126045 VALUE OF RADIATION THERAPY - PROJECT EXAMINES THE COMPARATIVE VALUE OF RADIOTHERAPY IN ORDER TO GENERATE THE EVIDENCE NEEDED TO IMPROVE CANCER OUTCOMES WHILE SLOWING THE GROWTH OF HEALTHCARE SPENDING. 24236 TOXICITY MANAGEMENT PROJECT - DEALS WITH THE MANAGEMENT AND ON-GOING FOLLOW-UP OF ADVERSE EFFECTS RELATED TO RADIATION THERAPY. IT WILL IMPROVE COMMUNICATION AND KNOWLEDGE AMONG NON-RADIATION THERAPY HEALTHCARE PROVIDERS IN ORDER TO IMPROVE PATIENT OUTCOMES AND QUALITY OF LIFE METRICS. 17352 OTHER PROGRAMS 11785 RESEARCH COMMITTEE 29137 181281 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 4 0 1 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 1 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 IL VA X PATRICIA B LAWLOR 7035021550 251 18TH ST SOUTH 8TH FLOOR ARLINGTON VA 22202 DEBORAH A KUBAN PRESIDENT 1.00 X X 0 0 0 COLLEEN A F LAWTON VICE PRESIDENT 1.00 2.00 X X 0 0 0 TIMOTHY E GUERTIN TRUSTEE AND TREASURER 1.00 X X 0 0 0 THEODORE S LAWRENCE IMMEDIATE PAST PRESIDENT 1.00 X X 0 0 0 DAVID C BEYER TRUSTEE - UNTIL 09/2015 1.00 2.00 X 0 30000 0 THEODORE L DEWEESE TRUSTEE 1.00 2.00 X 0 0 0 BRUCE HAFTY TRUSTEE 1.00 2.00 X 0 0 0 JAMES P HOEY TRUSTEE 1.00 X 0 0 0 JOSEPH K JACHINOWSKI TRUSTEE 1.00 X 0 0 0 BRIAN D KAVANAGH TRUSTEE - UNTIL 11/2015 1.00 2.00 X 0 0 0 CHRISTOPHER M ROSE TRUSTEE 1.00 X 0 0 0 CR THOMAS JR TRUSTEE - UNTIL 09/2015 1.00 X 0 0 0 TIM WILLIAMS TRUSTEE 1.00 X 0 0 0 J FRANK WILSON TRUSTEE 1.00 X 0 0 0 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 4.00 36.00 X 0 636023 98484 0 666023 98484 0 0 1 0 CHERYL REINHARDT 313 EATONS LANDING DRIVE ANNAPOLIS MD 21401 FUNDRAISING AND OTHER CONSULTING 155439 1 177912 410744 588656 221641 221641 4052858 3682305 370553 370553 370553 1180850 0 0 592194 X 126045 126045 105320 20227 78180 6913 3640 3540 100 14300 14300 99888 99888 56447 56447 88230 18952 67814 1464 1556 1556 39003 1922 10301 26780 922 50 872 619 619 41241 354 29034 11853 73 10 63 3632 3632 LOSS ON UNCOLLECTIBLES 153300 153300 OVERHEAD ALLOCATION 53316 10241 39575 3500 DUES AND PUBLICATIONS 11323 685 10638 MISCELLANEOUS 226 226 81 81 799162 181281 453735 164146 240332 192954 1057936 604040 1066256 763985 400 2850 9607107 9980758 22047 16755 11994078 11561342 3795 10959 100000 0 19021 6165 122816 17124 X 2439996 2054358 213503 0 9217763 9489860 11871262 11544218 11994078 11561342 381688 -708732 0 X 0 1 X 1 0 X X 1 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 420943164 9 0 10000 0 1 10000 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 FORM 990, SCHEDULE A, PART IV, LINE 3B ROI IS THE SUPPORTING ORGANIZATION FOR THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A 501(C)(6) ORGANIZATION. ROI PERFORMED THE 509(A)(2) TEST FOR ASTRO AND FOUND THAT ASTRO'S SUPPORT PERCENTAGE EXCEEDS THE 33% MINIMUM OF PUBLIC SUPPORT THAT WOULD BE A REQUIREMENT IF ASTRO WERE DESCRIBED AS SUCH AN ENTITY. ACCORDINGLY, ROI IS ELIGIBLE TO SUPPORT ASTRO. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9431266 272097 -172985 412701 9117677 9041538 361072 441358 412702 9431266 8335418 521273 1201604 976994 9081301 7698054 637364 853667 853667 8335418 0.00000 1.00000 0.00000 0 0 0 DUE TO ASTRO 6165 6165 X 455880 -708732 40209 -668523 1124403 56447 56447 1180850 782924 40209 40209 742715 56447 56447 799162 PART V, LINE 4: CURRENTLY, THE ENDOWMENT FUND IS A PERMANENTLY RESTRICTED FUND WHICH IS NOT AVAILABLE FOR USE. PART X, LINE 2: ROI PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEAR ENDED DECEMBER 31, 2015, AND DETERMINED THAT THERE ARE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. X X X X X 1 CHERYL REINHARDT 313 EATONS LANDING DRIVE ANNAPOLIS MD 21401 FUNDRAISING 0 339341 155439 239453 339341 155439 239453 VA 1 UT SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BOULEVARD DALLAS TX 75390 756002868 501(C)(3) 95355 RESEARCH GRANT COLUMBIA UNIVERSITY 630 W 168TH STREEET BOX 49 NEW YORK NY 10032 135598093 501(C)(3) 20690 RESEARCH GRANT AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 501(C)(6) 10000 GENERAL SUPPORT 2 1 PART I, LINE 2: AS PER A SIGNED AGREEMENT LETTER, ROI REQUIRES ANY DEVIATION FROM THE FUNDED GRANT PROPOSAL TO BE SUBMITTED IMMEDIATELY IN WRITING TO ROI. IN ADDITION, AN INTERIM PROGRESS REPORT AND A FINAL REPORT ARE COLLECTED WHICH SUMMARIZE PROGRESS MADE AND EXPENDITURES. 0 0 0 0 0 0 0 0 0 LAURA I THEVENOT EX-OFFICIO, EXECUTIVE DIRECTOR 0 550241 0 85782 0 0 0 55500 0 42984 0 734507 0 0 PART I, LINE 3 ROI DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). AN INDEPENDENT CONSULTANT PERFORMED MARKET SURVEY TO DEVELOP SALARY STRUCTURE AND RANGES. ASTRO'S PRACTICE IS TO COMPLETE A MARKET SURVEY EVERY THREE YEARS; THIS WAS LAST COMPLETED FOR THE EX-OFFICIO, EXECUTIVE DIRECTOR IN 2012. THE EX-OFFICIO, EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY A SUBCOMMITTEE OF THE BOARD USING COMPARABLE SALARIES OF SIMILAR EXECUTIVE DIRECTOR POSITIONS OF NONPROFIT MEDICAL ORGANIZATIONS. THIS REVIEW WAS DISCUSSED WITH THE BOARD OF DIRECTORS AND THE FINAL DETERMINATION WAS MADE BY THE EXECUTIVE COMMITTEE. FORM 990, PART III, LINE 3 AS OF JUNE 2014, ROI IS NO LONGER INVOLVED IN THE NATIONAL RADIATION ONCOLOGY REGISTRY PROGRAM. FORM 990, PART VI, SECTION A, LINE 3 ALL MANAGEMENT FUNCTIONS OF ROI ARE CONTROLLED BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO), A RELATED ORGANIZATION EXEMPT UNDER SECTION 501(C)(6). FORM 990, PART VI, SECTION A, LINE 4 DURING THE YEAR ENDED DECEMBER 31, 2015 ROI MADE CHANGES TO OUR BYLAWS WHICH AFFECTED THE COMPOSITION OF OUR BOARD OF TRUSTEES. FORM 990, PART VI, SECTION B, LINE 11 THE FEDERAL FORM 990 IS PREPARED BY OUR EXTERNAL TAX ACCOUNTANTS. THE DRAFT IS PROVIDED TO OUR FINANCE STAFF FOR REVIEW BEFORE BEING SUBMITTED TO THE CFO, CEO, AND TREASURER OF ASTRO FOR THEIR REVIEW AND APPROVAL. THE REVISED DRAFT IS THEN PROVIDED TO THE FULL BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ROI'S OFFICERS, DIRECTORS, KEY EMPLOYEES, AND VOLUNTEERS ARE REQUIRED TO FILL OUT DISCLOSURE FORMS ON AN ANNUAL BASIS AND TO UPDATE THEIR DISCLOSURE FORMS UPON ANY MATERIAL CHANGE IN THE INTERIM. THESE DISCLOSURE FORMS ARE REVIEWED IN ORDER TO IDENTIFY AND ADDRESS ANY POTENTIAL CONFLICTS OF THESE INDIVIDUALS. FORM 990, PART VI, SECTION C, LINE 19 THE ANNUAL REPORT WITH SUMMARY FINANCIAL STATEMENTS IS DISTRIBUTED TO MEMBERS AND IS AVAILABLE FOR MEMBERS ON OUR WEBSITE. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON OUR WEBSITE. FORM 990, PART IX, LINE 11G PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 18,952. MANAGEMENT AND GENERAL EXPENSES 67,814. FUNDRAISING EXPENSES 1,464. TOTAL EXPENSES 88,230. AMERICAN SOCIETY FOR RADIATION ONCOLOGY 251 18TH STREET SOUTH 8TH FLOOR ARLINGTON VA 22202 420943164 MEMBERSHIP SOCIETY IL 501(C)(6) N/A N/A 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 AMERICAN SOCIETY FOR RADIATION ONCOLOGY C 177912 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY N 53314 FMV AMERICAN SOCIETY FOR RADIATION ONCOLOGY O 105322 FMV